Navigation Links
ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes
Date:11/10/2008

ATLANTA, Nov. 10 /PRNewswire/ -- The American Academy of Ophthalmology (AAO) 2008 Annual Meeting -- ScienceBased Health, a leading provider of premium nutraceuticals for eye health, today announced the launch of DiaVis, a specialized dietary supplement to support the visual and overall health of those with diabetes.

24 million Americans -- 8% of the population and nearly 25% of those 60 and older -- currently suffer from diabetes. When added to the 57 million Americans with pre-diabetes, an astounding 81 million Americans either have the condition or are considered at risk according to 2007 prevalence data from the CDC. Pre-diabetes, characterized by elevated blood sugar levels, is a precursor of adult-onset diabetes.

Diabetes is a disease in which the body does not produce or properly use insulin. As a result, blood glucose levels become too high. Those with diabetes are at an increased risk for developing a number of complications, such as heart disease, stroke and retinopathy. Retinopathy, estimated to affect up to 80% of those with diabetes over time, is the most common diabetic eye disease and a leading cause of blindness.

Research has identified nutrients that may be low in diabetics due to inadequate nutrient intake, increased excretion, and altered nutrient requirements due to higher oxidative stress or use of diabetes-related medications. Some studies have found diabetics and those with retinopathy to be low in antioxidants. Antioxidants have been found to play an important role in helping to combat oxidative stress, which plays a role in developing diabetic complications.

DiaVis delivers a blend of key antioxidants, including Pycnogenol(R), and other nutrients found to play a role in helping to combat oxidative stress and inflammation, and that tend to be marginally low in those with diabetes. Additionally, DiaVis delivers ingredients found to play a role in normal glucose metabolism and retinal vessel health.

"DiaVis was developed for those with diabetes as well as the overwhelming number of people with pre-diabetes, said Alain Magro, president, ScienceBased Health. "Research shows that damage to the body is already occurring in the pre-diabetes phase and that certain nutrients can play a crucial role in bolstering the body's defenses. We believe that DiaVis represents the most advanced scientific research on the role of nutrition in diabetic health."

DiaVis is now available through eyecare practitioners or ScienceBased Health: 888.433.4726; http;//www.sciencebasedhealth.com. DiaVis retails for $34.95 (30 day supply).

About ScienceBased Health

ScienceBased Health, a privately held company, develops and markets evidence-based nutraceuticals for eye health. The formulations, created by leading physicians, nutrition scientists and researchers, are based on the latest scientific research and are recommended by several thousand ophthalmologists and optometrists nationwide. The Company developed HydroEye(R), a patented, oral formulation for dry eyes; OcularProtect(R), a comprehensive multinutrient for eyes and overall body health; MacularProtect Complete(R) and MacularProtect Complete(R)-S, powerful formulations, based on AREDS and other advanced research, to preserve macular and whole body health; Optic Nerve Formula(R), a powerful formulation to protect optic nerve health; DiaVis(TM), a targeted formulation for those with diabetes and at risk for diabetes; and other high quality products for eye and body health. The products are made from premium ingredients and manufactured according to highest quality standards. For more information, contact ScienceBased Health at: (888) 433-4726 or visit: http://www.sciencebasedhealth.com.


'/>"/>
SOURCE ScienceBased Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc.
2. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
3. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
4. ViroPharma to Present at Three November Healthcare Conferences
5. Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference
6. Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference
7. Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
8. APS Healthcare Moves Headquarters to White Plains, NY
9. BioMarin to Present at the Credit Suisse Healthcare Conference
10. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility ... Jake Lubinski will be traveling to Germany on December 6th. Mr. Lubinski will ... to discuss the benefits of a viscoelastic total disc replacement. , AxioMed received ...
(Date:12/5/2016)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... Safety Monitoring Board (DSMB) for the Company,s Phase ... patients has completed a second planned safety review ... planned without any modifications. The DSMB reviewed available ... efficacy concerns were identified. The DSMB will conduct ...
(Date:12/5/2016)... Research and Markets has announced the addition of Jain ... Companies" to their offering. ... , , ... development of sequencing technologies, and their applications. Current large and ... Various applications of sequencing are described including those for genetics, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... studies. A microbiome impact grant award has been made to Dr. Renato Polimanti ... smoking and drinking on the oral microbiome. Grant proposals have been vetted by ...
Breaking Biology Technology:
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016  AIC announces that it has just released a ... organizations that require high-performance scale-out plus high speed data transfer storage solutions. ... ... ... Setting up a high performance ...
Breaking Biology News(10 mins):